Comments
Loading...

Verastem Analyst Ratings

VSTMNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$34.00
Lowest Price Target1
$5.00
Consensus Price Target1
$15.91

Verastem Analyst Ratings and Price Targets | NASDAQ:VSTM | Benzinga

Verastem Inc has a consensus price target of $15.91 based on the ratings of 12 analysts. The high is $34 issued by Cantor Fitzgerald on July 6, 2023. The low is $5 issued by BTIG on October 5, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Jefferies, and Mizuho on May 9, 2025, April 10, 2025, and April 9, 2025, respectively. With an average price target of $12.33 between HC Wainwright & Co., Jefferies, and Mizuho, there's an implied 62.07% upside for Verastem Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Dec 24
3
Jan
3
Mar
2
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Jefferies
Mizuho
Guggenheim
RBC Capital

1calculated from analyst ratings

Analyst Ratings for Verastem

Buy NowGet Alert
05/09/2025Buy Now83.97%HC Wainwright & Co.
Sean Lee44%
$10 → $14MaintainsBuyGet Alert
04/10/2025Buy Now97.11%Jefferies
Kelly Shi39%
→ $15Initiates → BuyGet Alert
04/09/2025Buy Now5.12%Mizuho
Mara Goldstein49%
$9 → $8MaintainsOutperformGet Alert
03/24/2025Buy Now83.97%Guggenheim
Michael Schmidt9%
$13 → $14MaintainsBuyGet Alert
03/24/2025Buy Now31.41%HC Wainwright & Co.
Sean Lee44%
$7 → $10MaintainsBuyGet Alert
03/21/2025Buy Now83.97%RBC Capital
Gregory Renza65%
$16 → $14MaintainsOutperformGet Alert
01/31/2025Buy Now18.27%B. Riley Securities
Kalpit Patel43%
$7 → $9MaintainsBuyGet Alert
01/24/2025Buy Now—Guggenheim
Michael Schmidt9%
—ReiteratesBuy → BuyGet Alert
01/07/2025Buy Now110.25%RBC Capital
Gregory Renza65%
$13 → $16MaintainsOutperformGet Alert
12/19/2024Buy Now18.27%Mizuho
Mara Goldstein49%
$7 → $9MaintainsOutperformGet Alert
12/19/2024Buy Now-8.02%HC Wainwright & Co.
Sean Lee44%
$7 → $7ReiteratesBuy → BuyGet Alert
10/18/2024Buy Now70.83%RBC Capital
Gregory Renza65%
$13 → $13ReiteratesOutperform → OutperformGet Alert
10/18/2024Buy Now—Cantor Fitzgerald
Pete Stavropoulos44%
—Reiterates → OverweightGet Alert
10/18/2024Buy Now-8.02%HC Wainwright & Co.
Sean Lee44%
$7 → $7ReiteratesBuy → BuyGet Alert
09/30/2024Buy Now70.83%Guggenheim
Michael Schmidt9%
→ $13Initiates → BuyGet Alert
08/13/2024Buy Now97.11%Truist Securities
Srikripa Devarakonda41%
$18 → $15MaintainsBuyGet Alert
08/12/2024Buy Now-8.02%HC Wainwright & Co.
Sean Lee44%
$17.5 → $7MaintainsBuyGet Alert
08/09/2024Buy Now70.83%RBC Capital
Gregory Renza65%
$16 → $13MaintainsOutperformGet Alert
07/24/2024Buy Now-8.02%B. Riley Securities
Kalpit Patel43%
$21 → $7MaintainsBuyGet Alert
07/08/2024Buy Now136.53%Truist Securities
Srikripa Devarakonda41%
$34 → $18MaintainsBuyGet Alert
05/29/2024Buy Now162.81%Alliance Global Partners
Jeff Grampp58%
$34 → $20MaintainsBuyGet Alert
05/28/2024Buy Now110.25%RBC Capital
Gregory Renza65%
$32 → $16MaintainsOutperformGet Alert
05/28/2024Buy Now129.96%HC Wainwright & Co.
Sean Lee44%
$17.5 → $17.5ReiteratesBuy → BuyGet Alert
05/13/2024Buy Now129.96%HC Wainwright & Co.
Sean Lee44%
$17.5 → $17.5ReiteratesBuy → BuyGet Alert
03/19/2024Buy Now129.96%HC Wainwright & Co.
Sean Lee44%
→ $17.5ReiteratesBuy → BuyGet Alert
03/15/2024Buy Now320.5%RBC Capital
Gregory Renza65%
$32 → $32ReiteratesOutperform → OutperformGet Alert
11/21/2023Buy Now254.8%BTIG
Justin Zelin38%
→ $27Assumes → BuyGet Alert
11/15/2023Buy Now346.78%Truist Securities
Srikripa Devarakonda41%
$39 → $34MaintainsBuyGet Alert
09/29/2023Buy Now175.95%B. Riley Securities
Kalpit Patel43%
$21 → $21ReiteratesBuy → BuyGet Alert
09/27/2023Buy Now175.95%B. Riley Securities
Kalpit Patel43%
→ $21Initiates → BuyGet Alert
08/29/2023Buy Now373.06%Mizuho
Mara Goldstein49%
→ $36ReiteratesBuy → BuyGet Alert
08/09/2023Buy Now320.5%RBC Capital
Gregory Renza65%
$34 → $32MaintainsOutperformGet Alert
07/11/2023Buy Now412.48%Truist Securities
Srikripa Devarakonda41%
$60 → $39MaintainsBuyGet Alert
07/06/2023Buy Now346.78%Cantor Fitzgerald
Alethia Young67%
→ $34ReiteratesOverweight → OverweightGet Alert
07/03/2023Buy Now346.78%RBC Capital
Gregory Renza65%
$36 → $34MaintainsOutperformGet Alert
06/27/2023Buy Now688.44%Truist Securities
Srikripa Devarakonda41%
$60 → $60ReiteratesBuy → BuyGet Alert
06/23/2023Buy Now688.44%Truist Securities
Srikripa Devarakonda41%
→ $60ReiteratesBuy → BuyGet Alert
06/15/2023Buy Now373.06%Mizuho
Mara Goldstein49%
$24 → $36UpgradeNeutral → BuyGet Alert
05/10/2023Buy Now-73.72%HC Wainwright & Co.
Sean Lee44%
$3 → $2MaintainsBuyGet Alert
03/30/2023Buy Now-73.72%Mizuho
Mara Goldstein49%
→ $2Initiates → NeutralGet Alert
03/15/2023Buy Now-60.58%RBC Capital
Gregory Renza65%
→ $3Reiterates → OutperformGet Alert
03/15/2023Buy Now-60.58%HC Wainwright & Co.
Sean Lee44%
→ $3Reiterates → BuyGet Alert
11/07/2022Buy Now-60.58%HC Wainwright & Co.
Sean Lee44%
$5 → $3MaintainsBuyGet Alert
10/05/2022Buy Now-34.3%BTIG
Robert Hazlett29%
$8 → $5MaintainsBuyGet Alert

FAQ

Q

What is the target price for Verastem (VSTM) stock?

A

The latest price target for Verastem (NASDAQ:VSTM) was reported by HC Wainwright & Co. on May 9, 2025. The analyst firm set a price target for $14.00 expecting VSTM to rise to within 12 months (a possible 83.97% upside). 23 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Verastem (VSTM)?

A

The latest analyst rating for Verastem (NASDAQ:VSTM) was provided by HC Wainwright & Co., and Verastem maintained their buy rating.

Q

When was the last upgrade for Verastem (VSTM)?

A

The last upgrade for Verastem Inc happened on June 15, 2023 when Mizuho raised their price target to $36. Mizuho previously had a neutral for Verastem Inc.

Q

When was the last downgrade for Verastem (VSTM)?

A

There is no last downgrade for Verastem.

Q

When is the next analyst rating going to be posted or updated for Verastem (VSTM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Verastem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Verastem was filed on May 9, 2025 so you should expect the next rating to be made available sometime around May 9, 2026.

Q

Is the Analyst Rating Verastem (VSTM) correct?

A

While ratings are subjective and will change, the latest Verastem (VSTM) rating was a maintained with a price target of $10.00 to $14.00. The current price Verastem (VSTM) is trading at is $7.61, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch